PACIFIC IMMUNOLOGY

PACIFIC IMMUNOLOGY specializes in the development and production of monospecific antibodies for research and diagnostic applications, leveraging advanced immunological techniques to generate highly targeted reagents. Their core capabilities include animal immunization, hybridoma technology, monoclonal antibody purification, and rigorous characterization of antibody specificity and affinity. The company demonstrates deep expertise in custom antibody services tailored to meet precise scientific requirements, with an emphasis on reproducibility, batch consistency, and validation for use in immunoassays, flow cytometry, and therapeutic research. Their technical differentiation lies in precision-driven antigen design and controlled production workflows that ensure minimal cross-reactivity and high functional performance. The contractor has delivered services exclusively to the Department of Health and Human Services, supporting critical biomedical research initiatives through specialized antibody production. This relationship suggests a focused engagement with HHS components such as NIH or CDC, where monospecific reagents are essential for infectious disease diagnostics, vaccine development, and biomarker discovery. The nature of the work indicates a trusted, mission-aligned partnership grounded in scientific rigor and regulatory compliance. PACIFIC IMMUNOLOGY operates primarily under NAICS 541380, which encompasses testing laboratories and services involving biological reagent development. This positions them within the life sciences contract research space, serving pharmaceutical, academic, and government research entities requiring validated antibody tools. Their market niche is defined by niche, high-value antibody production rather than broad diagnostic testing, distinguishing them from general clinical lab providers. As a small business structured as a 2L entity based in Ramona, California, PACIFIC IMMUNOLOGY maintains a lean, specialized operational footprint. The company currently holds no formal government certifications, relying instead on technical credibility and demonstrated performance in specialized immunological services to compete in federal research markets. Their geographic presence is centered in Southern California, a hub for biotech innovation and federal research contracting.